HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Maximilian J Hochmair Selected Research
Maximilian J Hochmair Research Topics
Disease
31
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2024 - 08/2017
14
Neoplasms (Cancer)
02/2024 - 11/2017
10
Brain Neoplasms (Brain Tumor)
06/2022 - 08/2017
8
Disease Progression
02/2024 - 08/2017
7
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2024 - 12/2018
7
Lung Neoplasms (Lung Cancer)
04/2023 - 01/2017
3
Neoplasm Metastasis (Metastasis)
02/2022 - 01/2017
2
Adenocarcinoma of Lung
01/2021 - 01/2019
2
Dyspnea (Shortness of Breath)
11/2020 - 11/2017
2
Chest Pain (Chest Pains)
11/2020 - 01/2020
2
Cough
11/2020 - 01/2020
1
Circulating Neoplastic Cells
02/2024
1
Pleural Effusion (Pleural Effusions)
01/2024
1
Hypertension (High Blood Pressure)
04/2022
1
Malignant Mesothelioma
04/2022
1
Sarcopenia
02/2022
1
Edema (Dropsy)
01/2022
1
Febrile Neutropenia
01/2021
1
Pneumonia (Pneumonitis)
01/2021
1
Pulmonary Embolism
01/2021
1
Dehydration (Water Stress)
01/2021
1
Respiratory Insufficiency (Respiratory Failure)
01/2021
1
Sudden Death
01/2021
1
Thrombocytopenia (Thrombopenia)
01/2021
1
Hepatitis
01/2021
1
Interstitial Lung Diseases (Interstitial Lung Disease)
01/2021
1
Heart Arrest (Cardiac Arrest)
01/2021
1
Sepsis (Septicemia)
01/2021
1
Multiple Organ Failure (MODS)
01/2021
1
Pancytopenia
01/2021
1
Enterocolitis
01/2021
1
Neutropenia
01/2021
1
Fatigue
11/2020
1
Weight Loss (Weight Reduction)
11/2017
1
Clinical Deterioration
11/2017
1
Adenocarcinoma
11/2017
Drug/Important Bio-Agent (IBA)
11
Platinum
IBA
02/2024 - 05/2018
11
osimertinib
IBA
01/2022 - 01/2018
10
Tyrosine Kinase Inhibitors
IBA
04/2024 - 01/2017
9
brigatinib
IBA
12/2022 - 08/2017
7
Etoposide (VP 16)
FDA Link
Generic
12/2023 - 12/2018
7
Crizotinib
IBA
12/2022 - 08/2017
7
ErbB Receptors (EGF Receptor)
IBA
01/2022 - 01/2019
7
Afatinib
IBA
01/2022 - 11/2018
6
durvalumab
IBA
02/2024 - 11/2019
6
Anaplastic Lymphoma Kinase
IBA
12/2022 - 08/2017
5
Carboplatin (JM8)
FDA Link
Generic
12/2023 - 12/2018
5
pembrolizumab
IBA
10/2023 - 11/2017
4
Biomarkers (Surrogate Marker)
IBA
03/2024 - 02/2022
3
DNA (Deoxyribonucleic Acid)
IBA
05/2024 - 01/2018
3
Pemetrexed (MTA)
FDA Link
10/2023 - 01/2020
3
Cisplatin (Platino)
FDA Link
Generic
10/2023 - 11/2020
3
B7-H1 Antigen
IBA
10/2020 - 05/2018
2
atezolizumab
IBA
12/2023 - 12/2018
2
tremelimumab
IBA
10/2023 - 01/2021
2
Circulating Tumor DNA
IBA
01/2021 - 01/2021
2
lorlatinib
IBA
11/2020 - 01/2017
1
mobocertinib
IBA
04/2024
1
Cytokines
IBA
01/2024
1
Immune Checkpoint Inhibitors
IBA
04/2023
1
Asbestos
IBA
04/2022
1
capmatinib
IBA
01/2022
1
Enzymes
IBA
01/2022
1
Creatinine
IBA
01/2022
1
Cell-Free Nucleic Acids
IBA
01/2019
Therapy/Procedure
15
Therapeutics
03/2024 - 01/2017
6
Immunotherapy
03/2024 - 11/2017
6
Drug Therapy (Chemotherapy)
04/2023 - 08/2017
3
Time-to-Treatment
01/2022 - 09/2019
2
Radiotherapy
06/2022 - 10/2018
1
Cranial Irradiation
06/2022
1
Combined Modality Therapy
04/2022
1
Duration of Therapy
05/2020